CADIAN CAPITAL MANAGEMENT, LP

Position in BSX — Boston Scientific Corp

CIK 1423686 NEW YORK, NY

Position in BSX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$47,167,033

+$36,499,533 QoQ

Shares Held

1,105,132

+550.1% QoQ

Ownership

0.076%

of shares outstanding

% of Portfolio

3.57%

of 13F equity value

Holder Rank

#142

of 1,477 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CADIAN CAPITAL MANAGEMENT, LP holds $151,468,147 across 4 Medical Devices names. BSX ranks #2 (31.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SIBN	SI-BONE, Inc.	3,347,574	$54,632,407
2	BSX	Boston Scientific Corp This page	1,105,132	$47,167,033
3	TCMD	Tactile Systems Technology Inc	1,576,940	$46,961,273
4	MXCT	Maxcyte, Inc.	2,201,166	$2,707,434

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$47,167,033	1,105,132	+550.1%	Shares	Sole	2026-08-14
2026-03-31	$10,667,500	170,000	—	Shares	Sole	2026-05-15
No filing history on record for this holder in this stock.